查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386384

DNA 疫苗市場報告：2030 年趨勢、預測與競爭分析

DNA Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

DNA疫苗趨勢與預測

預計到 2030 年，全球 DNA 疫苗市場將達到 8 億美元，2024 年至 2030 年複合年成長率為 6.5%。該市場的主要驅動力是人類和動物癌症和感染疾病發病率的增加，以及對透過基因工程 DNA 細胞直接產生抗原的疫苗的需求不斷成長。僅此而已。全球DNA疫苗市場前景廣闊，為獸醫院和獸醫診所帶來市場機會。

DNA 疫苗市場洞察

Lucintel 預測 Oncept 將仍然是最大的區隔市場，因為它在避免動物黑色素瘤擴散方面具有重要用途。

由於獸藥領域主要企業的存在和完善的組織結構，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球DNA疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球DNA疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 依產品類型分類的全球 DNA 疫苗市場
    • 概念
    • West Nile-Innovator
    • Apex-IHN
  • 全球 DNA 疫苗市場（依類型）
    • 治療性疫苗
    • 預防性疫苗
  • 全球 DNA 疫苗市場（依最終用途）
    • 動物診所
    • 動物醫院

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球DNA疫苗市場區域分佈
  • 北美DNA疫苗市場
  • 歐洲DNA疫苗市場
  • 亞太地區DNA疫苗市場
  • 其他地區DNA疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依產品類型分類的全球 DNA 疫苗市場成長機會
    • 依類型分類的全球 DNA 疫苗市場成長機會
    • 全球 DNA 疫苗市場成長機會（依最終用途）
    • 全球 DNA 疫苗市場成長機會（依地區）
  • 全球DNA疫苗市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球DNA疫苗市場產能擴張
    • 全球DNA疫苗市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Geovax Labs
  • Viatris
  • Inovio Pharmaceuticals
  • Zydus Cadila
  • Geneone Life Science
  • Eli-Lilly
  • Zoetis
  • Takara Holdings
  • Boehringer Ingelheim
  • Genexine
簡介目錄

DNA Vaccine Trends and Forecast

The future of the global DNA vaccine market looks promising with opportunities in the veterinary clinic and veterinary hospital markets. The global DNA vaccine market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurrence of cases of cancer and infectious diseases in human and animals and growing demand for these vaccines among genetically engineered DNA cells to directly produce an antigen.

A more than 150-page report is developed to help in your business decisions.

DNA Vaccine by Segment

The study includes a forecast for the global DNA vaccine by product type, type, end use, and region.

DNA Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Oncept
  • West Nile-Innovator
  • Apex-IHN

DNA Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutic Vaccines
  • Prophylactic Vaccines

DNA Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Clinics
  • Veterinary Hospitals

DNA Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of DNA Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies DNA vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the DNA vaccine companies profiled in this report include-

  • Geovax Labs
  • Viatris
  • Inovio Pharmaceuticals
  • Zydus Cadila
  • Geneone Life Science
  • Eli-Lilly
  • Zoetis
  • Takara Holdings
  • Boehringer Ingelheim
  • Genexine

DNA Vaccine Market Insights

Lucintel forecasts that oncept will remain the largest segment due to its significant usage to avoid prevalence of canine melanoma cancer in animals.

North America is expected to witness highest growth over the forecast period due to the presence of major key players and existence of well-established veterinary organizational structures in the region.

Features of the Global DNA Vaccine Market

Market Size Estimates: DNA vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: DNA vaccine market size by product type, type, end use, and region in terms of value ($B).

Regional Analysis: DNA vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, types, end uses, and regions for the DNA vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the DNA vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the DNA vaccine market size?

Answer: The global DNA vaccine market is expected to reach an estimated $0.8 billion by 2030.

Q.2 What is the growth forecast for DNA vaccine market?

Answer: The global DNA vaccine market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the DNA vaccine market?

Answer: The major drivers for this market are rising occurrence of cases of cancer and infectious diseases in human and animals and growing demand for these vaccines among genetically engineered DNA cells to directly produce an antigen.

Q4. What are the major segments for DNA vaccine market?

Answer: The future of the DNA vaccine market looks promising with opportunities in the therapeutic and prophylactic markets.

Q5. Who are the key DNA vaccine market companies?

Answer: Some of the key DNA vaccine companies are as follows:

  • Geovax Labs
  • Viatris
  • Inovio Pharmaceuticals
  • Zydus Cadila
  • Geneone Life Science
  • Eli-Lilly
  • Zoetis
  • Takara Holdings
  • Boehringer Ingelheim
  • Genexine

Q6. Which DNA vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that oncept will remain the largest segment due to its significant usage to avoid prevalence of canine melanoma cancer in animals.

Q7. In DNA vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the presence of major key players and existence of well-established veterinary organizational structures in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the DNA vaccine market by product type (oncept, west nile-innovator, and apex-IHN), type (therapeutic vaccines and prophylactic vaccines), end use (veterinary clinics and veterinary hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global DNA Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global DNA Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global DNA Vaccine Market by Product Type
    • 3.3.1: Oncept
    • 3.3.2: West Nile-Innovator
    • 3.3.3: Apex-IHN
  • 3.4: Global DNA Vaccine Market by Type
    • 3.4.1: Therapeutic Vaccines
    • 3.4.2: Prophylactic Vaccines
  • 3.5: Global DNA Vaccine Market by End Use
    • 3.5.1: Veterinary Clinics
    • 3.5.2: Veterinary Hospitals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global DNA Vaccine Market by Region
  • 4.2: North American DNA Vaccine Market
    • 4.2.2: North American DNA Vaccine Market by Type: Therapeutic Vaccines and Prophylactic Vaccines
  • 4.3: European DNA Vaccine Market
    • 4.3.1: European DNA Vaccine Market by Product Type: Oncept, West Nile-Innovator, and Apex-IHN
    • 4.3.2: European DNA Vaccine Market by Type: Therapeutic Vaccines and Prophylactic Vaccines
  • 4.4: APAC DNA Vaccine Market
    • 4.4.1: APAC DNA Vaccine Market by Product Type: Oncept, West Nile-Innovator, and Apex-IHN
    • 4.4.2: APAC DNA Vaccine Market by Type: Therapeutic Vaccines and Prophylactic Vaccines
  • 4.5: ROW DNA Vaccine Market
    • 4.5.1: ROW DNA Vaccine Market by Product Type: Oncept, West Nile-Innovator, and Apex-IHN
    • 4.5.2: ROW DNA Vaccine Market by Type: Therapeutic Vaccines and Prophylactic Vaccines

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global DNA Vaccine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global DNA Vaccine Market by Type
    • 6.1.3: Growth Opportunities for the Global DNA Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global DNA Vaccine Market by Region
  • 6.2: Emerging Trends in the Global DNA Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global DNA Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global DNA Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Geovax Labs
  • 7.2: Viatris
  • 7.3: Inovio Pharmaceuticals
  • 7.4: Zydus Cadila
  • 7.5: Geneone Life Science
  • 7.6: Eli-Lilly
  • 7.7: Zoetis
  • 7.8: Takara Holdings
  • 7.9: Boehringer Ingelheim
  • 7.10: Genexine